BENANOVA commercializes novel cost-efficient environmentally benign particle systems (EbNPs) made of natural materials, which can leverage the functional properties of bioactive agents.

A&G Pharmaceutical is a privately held theranostics company focused on the rapid development of monoclonal antibodies to disease-specific antigens as a basis for novel therapeutic and diagnostic products addressing a broad range of diseases.